NEXT

Next generation sequencing core

NEXT is a modern NGS core facility, consisting of a Laboratory, which allows high throughput, low cost, production-scale sequencing experiments, combined with a data-intensive computational infrastructure (8000+ cores HPC Cluster with 4PB storage). An infrastructure, unique in Italy, designed to provides specialized capabilities for tracking all-data procedures and biodata provenance, managing complex analysis workflows and results.

NEXT has recently acquired new instruments, including Illumina‘s most advanced sequencer, the NovaSeq X Plus.

For any information write to next@crs4.it, or fill the form below:

Services on NovaSeq X Plus

library preparation + sequencing + bioinformatics analisys + storage
RNA Seq
(~ 100 M Paired-end Reads)
miRNA Seq
(~10 M Single Reads)
Whole Genome Sequencing
Human | Animal | Plant | Microbial
WGS (~ 120 Gb = Coverage 30X)
Whole Exome Sequencing
Human | Animal | Plant | Microbial
WES (~ 15 Gb = Coverage 100X)

More Services

Metagenomics
On MiSeq
Custom Panels and Protocols
On NovaSeq X Plus | On MiSeq
Sequencing only
Tailored services
Lab or Remote

Our Next Generation Sequencing platform is available to the scientific community for collaborations in research projects.

OUR NGS LABORATORY

Our NGS Lab has been a pioneer in the use of NGS technology, starting from 2009 with the first sequencers produced by Illumina, two Genome Analyzers. By 2010, we upgraded to three HiSeq2000 sequencers, and later to the HiSeq3000. We have 15 years of experience, dozens of different applied protocols, and have processed thousands of samples of various types and origins.

Recent acquisitions have led to a technological upgrade of our laboratory, aimed at increasing the accuracy, reliability and production capacity of sequencing data.

The platform is directly interconnected with the HPC resources of the CRS4 computing center, a unique infrastructure in Italy that enables large-scale sequencing projects.
A web-accessible database will be integrated with a LIMS (Laboratory Information Management System) and analysis pipeline management system. The platform is designed to allow facility users to require analyses, perform customized investigations, and organize, consult, and update data related to their projects.

Illumina NovaSeq X Plus

the latest and and most powerful sequencer, with a production capacity of 120Tb/month

Tecan Infinite 200 Pro

plate reader for fluorometric quantification of nucleic acids and libraries

Agilent Fragment Analyzer 5300

Capillary electrophoresis (48 capillaries) for fragment analysis and quality control of nucleic acids

Illumina MiSeq

sequencer for metagenomics, small panels and other custom protocols.

Hamilton NGS STAR

Liquid Handler for Library Preparation with throughputs up to 96 sample libraries processed at once

Areas of interest

Sequencing of the human genome or a set of specific genes for the investigation of a wide range of DNA variations that can be causative or predisposing to disease, or involved in drug response modulation; analysis of the transcriptome (RNASeq) to highlight variations in gene expression; high-resolution HLA gene typing with ambiguity elimination; characterization of the microbiota to identify pathogens; characterization of bacterial and viral pathogen genomes for epidemiological studies or to understand mechanisms of drug resistance and virulence.

Information on the complete genome of multiple animal and plant species enables the selection of more productive and disease-resistant strains and their geographic traceability; analysis of environmental DNA metagenome in agri-food production chains for the detection of contaminating species (viruses, bacteria, fungi and parasites, animals and plants) or identification of pathogens that affect crop or livestock productivity; species authentication for food fraud control; detection of unauthorized GMOs in food products; molecular epidemiology investigations in cases of foodborne illness.

Technology facilitates the discovery of new pathogens (bacteria, viruses, and fungi) regardless of in vitro culture and knowledge of genotypic or phenotypic characteristics; comprehensive genome characterization of specific microorganisms, whether isolated or from a mixed sample; high-throughput screening, useful for epidemiological investigations.

This cutting-edge technology, thanks to its more sensitive and broad-spectrum analysis capabilities, allows simultaneous investigation of a considerable number and types of DNA polymorphic regions for individual identification, inference of phenotypic characteristics (iris color, hair color, skin complexion, height, age, predisposition to baldness, and facial morphology), and geographic origin. Furthermore, in cases where the sample is degraded, the analysis of the complete mitochondrial genome provides useful information for individual identification.

Sequencing of the human genome or a set of specific genes for the investigation of a wide range of DNA variations that can be causative or predisposing to disease, or involved in drug response modulation; analysis of the transcriptome (RNASeq) to highlight variations in gene expression; high-resolution HLA gene typing with ambiguity elimination; characterization of the microbiota to identify pathogens; characterization of bacterial and viral pathogen genomes for epidemiological studies or to understand mechanisms of drug resistance and virulence.

Information on the complete genome of multiple animal and plant species enables the selection of more productive and disease-resistant strains and their geographic traceability; analysis of environmental DNA metagenome in agri-food production chains for the detection of contaminating species (viruses, bacteria, fungi and parasites, animals and plants) or identification of pathogens that affect crop or livestock productivity; species authentication for food fraud control; detection of unauthorized GMOs in food products; molecular epidemiology investigations in cases of foodborne illness.

Technology facilitates the discovery of new pathogens (bacteria, viruses, and fungi) regardless of in vitro culture and knowledge of genotypic or phenotypic characteristics; comprehensive genome characterization of specific microorganisms, whether isolated or from a mixed sample; high-throughput screening, useful for epidemiological investigations.

This cutting-edge technology, thanks to its more sensitive and broad-spectrum analysis capabilities, allows simultaneous investigation of a considerable number and types of DNA polymorphic regions for individual identification, inference of phenotypic characteristics (iris color, hair color, skin complexion, height, age, predisposition to baldness, and facial morphology), and geographic origin. Furthermore, in cases where the sample is degraded, the analysis of the complete mitochondrial genome provides useful information for individual identification.

Our team

roberto-cusano
Roberto Cusano
Biotechnologist

- Next Lab Head -

jessica-milia
Gessica Milia
Biologist

- Researcher -

rossano-atzeni
Rossano Atzeni
Bioinformatician

- Researcher -

lidia-leoni
Lidia Leoni

Director of High Performance and Quantum Computing, Biosciences and Advanced Studies

For Hospitals, IRCSS, Universities, and other research institutions interested in establishing a collaboration, please send an email to roberto.cusano@crs4.it